Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 01676997 AND DT 2009 AND VI 27 AND IP 3
Results: 15
1
2
Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 233, doi. 10.1007/s10637-008-9163-y
- By:
- Publication type:
- Article
3
Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 203, doi. 10.1007/s10637-008-9158-8
- By:
- Publication type:
- Article
4
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 253, doi. 10.1007/s10637-008-9182-8
- By:
- Publication type:
- Article
5
N-benzoxazol-2-yl- N′-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 189, doi. 10.1007/s10637-008-9156-x
- By:
- Publication type:
- Article
6
A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 269, doi. 10.1007/s10637-008-9177-5
- By:
- Publication type:
- Article
7
Rhinitis and epistaxis in patients treated by anti-angiogenic therapy.
- Published in:
- 2009
- By:
- Publication type:
- Report
8
A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 275, doi. 10.1007/s10637-008-9178-4
- By:
- Publication type:
- Article
9
Publication biases and phase II trials investigating anticancer targeted therapies.
- Published in:
- 2009
- By:
- Publication type:
- Report
10
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 262, doi. 10.1007/s10637-008-9192-6
- By:
- Publication type:
- Article
11
Enhancement of the action of the antivascular drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA; ASA404) by non-steroidal anti-inflammatory drugs.
- Published in:
- 2009
- By:
- Publication type:
- Report
12
Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 214, doi. 10.1007/s10637-008-9159-7
- By:
- Publication type:
- Article
13
Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 223, doi. 10.1007/s10637-008-9161-0
- By:
- Publication type:
- Article
14
Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 246, doi. 10.1007/s10637-008-9170-z
- By:
- Publication type:
- Article
15
Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin).
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 241, doi. 10.1007/s10637-008-9169-5
- By:
- Publication type:
- Article